TSI Health Sciences gets Australian TGA approval
TSI Health Sciences has secured approval from the Australian Therapeutic Goods Administration (TGA) for manufacturing chondroitin sulfate sodium, thereby opening up another avenue of business for the Montana-headquartered company.